Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8‐color flow cytometry protocol in routine hematological practice

13 Sept 2013

Abstract excerpt

INTRODUCTION: Minimal residual disease (MRD) detection has become increasingly important for the assessment of therapy response in chronic lymphocytic leukemia (CLL). However, current MRD analysis methods, both molecular genetic and flow cytometric, are time-consuming and require experienced laboratory staff. METHODS: To reduce the demands of flow cytometric MRD detection in CLL, we have introduced a novel flow...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Immunodeficiency and Autoimmune Disorders
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24028768
DOI: 10.1111/ijlh.12149

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8‐color flow cytometry protocol in routine hematological practicePMID 24028768Read ↗

Performance of a novel 8-color flow cytometry panel in the detection of minimal residual disease assessment of chronic lymphocytic leukemiaSemantic proximity Read ↗

Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantationSemantic proximity Read ↗

Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR.Semantic proximity Read ↗

Minimal Residual Disease Detection in Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Comparison of flow cytometry and next-generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute's practical clinical experience.Semantic proximity Read ↗

Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemiaSemantic proximity Read ↗

Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigationSemantic proximity Read ↗

Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric AnalysisSemantic proximity Read ↗

Prognostic Implication of Early Minimal Residual Disease Evaluation in Patients with Chronic Myelomonocytic LeukemiaSemantic proximity Read ↗

The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.Semantic proximity Read ↗

Novel microfluidic device for measurable residual disease detection in acute leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.